Aytu BioScience Inc
NASDAQ: AYTU
$2.35
-$0.04 (-1.47%)
Closing Price on July 7, 2025
AYTU Stock Chart and Intraday Price
AYTU Stock Data
| Asset Type | Common Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 16200 WCR 18E, LOVELAND, CO, US |
| Fiscal Year End | June |
| Latest Quarter | 2023-12-31 |
| Market Cap | 17.76M USD |
| Shares Outstanding | 5,567,600 |
AYTU Articles
Some small companies are destined to be small forever. Others can grow into huge companies over time. What will be the story for Aytu BioScience?
Published:
Aytu BioScience is a coronavirus play after moving into testing and treatment.
Published:
Investors look at Aytu BioScience as it looks at expanding in the COVID testing field.
Published:
Aytu BioScience has a distribution agreement for a COVID-19 rapid test and is developing a potential UV light-based treatment.
Published:
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
Published:
Aytu Bioscience has moved very quickly, both to execute agreements for products that can have an impact on the COVID-19 pandemic and to raise the capital it will take to provide a return on...
Published:
Aytu BioScience shares made an incredible gain to start the week following the firm’s announcement in regards to a coronavirus treatment.
Published:
Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending 2,700 COVID-19 rapid tests to Denver for use with first responders.
Published:
There is plenty of competition among companies wanting to sell coronavirus test kits. Aytu Biosciences has placed a bet on its ability to help beat the coronavirus outbreak.
Published:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
Published:
Aytu BioScience was largely unknown until it announced that it had a test for COVID-19. Since then, it has seen a meteoric rise in its common stock price. Does the future look bright?
Published:
Aytu Bioscience stock has had investors on a roller-coaster over the past week. The commercial-stage specialty pharmaceutical company has a COVID-19 test kit, but it's not the only one.
Published:
It is not a new scenario where an illness or problem starts to become a big deal in the public and there is a small-cap company that “has a solution for that” which happen to be known by...
Published:
More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at some of the biggest movers on the day tied to COVID-19.
Published: